(2024-2033) Bone and Mineral Diagnostic Testing Market Size, Share, Trends, Industry Growth Analysis and Forecast | Abbott Laboratories, bioMérieux SA, DiaSorin S.p.A., QuidelOrtho Corporation

Overview and Scope
A bone and mineral diagnostic test is a medical treatment that determines the quantity of calcium and other minerals in a section of bone. This test is used to detect bone loss and osteoporosis, monitor osteoporosis therapy, and assess the risk of fractures.

Sizing and Forecast
The bone and mineral diagnostic testing market size has grown strongly in recent years. It will grow from $1.02 billion in 2023 to $1.08 billion in 2024 at a compound annual growth rate (CAGR) of 5.9%.  The  growth in the historic period can be attributed to aging population demands, prevalence of osteoporosis, awareness and education initiatives, clinical need for monitoring, fracture risk assessment.

The bone and mineral diagnostic testing market size is expected to see strong growth in the next few years. It will grow to $1.32 billion in 2028 at a compound annual growth rate (CAGR) of 5.0%.  The growth in the forecast period can be attributed to advancements in diagnostic technologies, increasing incidence of metabolic bone diseases, growing focus on preventive healthcare, integration with personalized medicine approaches. Major trends in the forecast period include integration of biochemical markers, telemedicine and remote monitoring, expansion of home-based testing kits, collaborations for research and innovation, emphasis on comprehensive diagnostic panels.

To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/bone-and-mineral-diagnostic-testing-global-market-report

The bone and mineral diagnostic testing market covered in this report is segmented –

1) By Product: Assays Or Consumables, Instruments
2) By Test Type: Enzyme-Linked Immunosorbent Assay (ELISA), Clinical Laboratory Improvement Amendments (CLIA), Other Test Types
3) By Application: Vitamin D Testing, Bone Metabolism

North America was the largest region in the bone and mineral diagnostic testing market in 2023. The regions covered in the bone and mineral diagnostic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/Discount?id=10731&type=discount

Major Driver Impacting Market Growth
An increase in the incidence of bone-related diseases is expected to propel the growth of the bone and mineral diagnostic testing market going forward. Bone-related diseases are ailments that alter the strength or flexibility of bones, making them weaker and more prone to fractures, and can cause symptoms such as bone pain, trouble moving, and an increased risk of bone fractures. Bone and mineral diagnostic tests, such as bone density tests, can assist in preventing bone diseases by identifying low bone density before osteoporosis grows, forecasting the risk of future fractures, and tracking the efficacy of ongoing osteoporosis treatment. The increasing incidence of bone-related diseases, coupled with growing awareness and technological advancements, is expected to fuel the growth of the bone and mineral diagnostic testing market. For instance, In May 2022, according to statistics published by Amgen, a US-based biotechnology company, states that every year, osteoporosis causes roughly 1.5 million fractures in the United States, resulting in $19 billion in associated costs. Furthermore, the annual number of fractures caused by osteoporosis is expected to rise by 68% from 2018 to 2040, i.e., from 1.9 million to 3.2 million. Therefore, an increase in the incidence of bone-related diseases will drive the bone and mineral diagnostic testing market.

Key Industry Players
Major companies operating in the bone and mineral diagnostic testing market report are Abbott Laboratories, bioMérieux SA, DiaSorin S.p.A., QuidelOrtho Corporation, Siemens Healthineers AG, F. Hoffmann-La Roche AG, GE HealthCare Technologies Inc., Hologic Inc., Beammed Ltd., Swissray International Inc., Osteosys Co. Ltd., Diagnostic Medical System SA, Medonica Co. Ltd., Epitope Diagnostics Inc., Alere Inc., Beckman Coulter Inc., Bio Rad Laboratories Inc., Calbiotech Inc., Roche Diagnostics India Pvt. Ltd., Ortho-Clinical Diagnostics, Enzo Life Sciences lnc., Medtronic plc, Thermo Fisher Scientific lnc., Sysmex Corporation, EKF Diagnostics, Bruker Corporation, Esaote SpA, Hitachi Ltd., Koninklijke Philips N.V., Mindray Medical International Limited, PerkinElmer Inc., Shimadzu Corporation, Toshiba Medical Systems Corporation, Waters Corporation, Danaher Corporation, Merck KGaA

The bone and mineral diagnostic testing  market report table of contents includes:

1. Executive Summary

2. Bone and Mineral Diagnostic Testing Characteristics

3. Bone and Mineral Diagnostic Testing Trends And Strategies

4. Bone and Mineral Diagnostic Testing – Macro Economic Scenario

5. Global Bone and Mineral Diagnostic Testing Size and Growth

…..

32. Global Bone and Mineral Diagnostic Testing Competitive Benchmarking

33. Global Bone and Mineral Diagnostic Testing Competitive Dashboard

34. Key Mergers And Acquisitions In The Bone and Mineral Diagnostic Testing

35. Bone and Mineral Diagnostic Testing Future Outlook and Potential Analysis

36. Appendix

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model